不同类型的降压药物对高血压患者脉搏波速度的影响(4)
 |
| 第1页 |
参见附件(2455KB，3页)。
[9] Goldberg RB,Temprosa M,Haffner S,et al.Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention:the Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group.Diabetes Care,2009,32(4):726-732.
[10] Nam JS,Park JS,Cho MH,et al.The association between pulse wave velocity and metabolic syndrome andadiponectin in patients with impaired fasting glucose:cardiovascular risks and adiponectin in IFG.Diabetes Res Clin Pract,2009,84(2):145-5.
[11] Kim SG,Ryu OH,Kim HY,et al.Effect of rosiglitazone on plasma adiponectin levels and arterial stiffness in subjects with prediabetes or nondiabetic metabolic syndrome.Eur J Endocrinol,2006,154(3):433-440.
[12] Ono Y,Nakaya Y,Bando S,et al.Telmisartan decreases plasma levels of asymmetrical dimethyl-L-arginine and improves lipid and glucose metabolism and vascular function.Int Heart J,2009,50(1):73-83.
[13] Ishikawa T,Hashimoto J,Morito R H,et al.Association of microal-Buminuriawith brachial-ankle pulse wave velocity the Ohasama study.Am J Hypertens,2008,21(4):413-418.
[14] Bmendonca MI,Reis RP,Sousa AC,et al.Pulse wave velocity and coronary risk stratification.Rev Port Cardiol,2009,28(2):155-711.
[15] Kim KH,Jeong MH,Cho SH,et al.Clinical effects of calcium channel blocker and Angiotensin converting enzyme inhibitor on endothelial function and arterial stiffness in patients with angina pectoris.J Korean Med Sci,2009,24(2):223-226.
[16] 姚树勇,路方红,孙晓静,等.高血压前期患者动脉硬度的变化.中国现代医生,2008,46(7):36-37.
您现在查看是摘要介绍页，详见PDF附件(2455KB，3页)。